Unicycive Therapeutics Inc.
UNCY | NASDAQ
$4.79
+$0.02 (+0.42%)
Sep 22, 2026, 10:37 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 675K | n/a | 951K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 211K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 284K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -211K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -284K | n/a | n/a | n/a | 675K | n/a | 951K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -10.14M | -8.44M | -7.22M | -7.34M | -6.96M | -7.99M | -9.26M | -6.25M | -7.4M | -9.2M | -6.31M | -5.94M | -4.32M | -4.2M | -5.33M | -5.55M | -3.64M | -3.54M | -2.75M | -4.72M | -779K | -731K |
Interest Income | 441K | 394K | 351K | 279K | 155K | 226K | 314K | 416K | 462K | 69K | 140K | 227K | 234K | 14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.72M | -12.82M | -14.67M | -6.01M | -6.45M | 570K | -21.53M | -4.1M | 9.86M | -20.96M | -7.8M | -4.33M | -3.84M | -14.58M | -5.33M | -5.56M | -3.64M | -3.54M | -2.75M | -5.2M | -1.1M | -964K |
Net Income | -1.72M | -12.82M | -14.67M | -6.01M | -6.45M | 570K | -21.53M | -4.1M | 9.86M | -20.96M | -7.8M | -4.33M | -3.84M | -14.58M | -5.33M | -5.56M | -3.64M | -3.54M | -2.75M | -5.2M | -1.1M | -964K |
Selling & General & Admin | 7.35M | 6.83M | 4.97M | 4.38M | 5.21M | 5.82M | 3.97M | 3.21M | 2.53M | 2.11M | 2.08M | 2.57M | 2.06M | 1.85M | 1.49M | 1.7M | 1.78M | 1.6M | 1.39M | 939K | 286K | 281K |
Research & Development | 2.79M | 1.61M | 2.25M | 2.96M | 1.75M | 2.17M | 5.29M | 3.05M | 4.87M | 6.81M | 4.23M | 3.37M | 2.27M | 3.03M | 3.84M | 4.8M | 1.86M | 1.93M | 1.36M | 3.78M | 493K | 450K |
Other Expenses | n/a | -211K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.14M | 8.23M | 7.22M | 7.34M | 6.96M | 7.99M | 9.26M | 6.25M | 7.4M | 8.92M | 6.31M | 5.94M | 4.32M | 4.88M | 5.33M | 6.51M | 3.64M | 3.54M | 2.75M | 4.72M | 779K | 731K |
Interest Expense | n/a | n/a | 27K | 15K | 13K | 15K | 20K | 15K | 16K | 20K | 19K | 18K | 32K | 12K | 3K | 3K | n/a | n/a | n/a | 55K | 321K | 252K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -284K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.14M | 8.44M | 7.22M | 7.34M | 6.96M | 7.99M | 9.26M | 6.25M | 7.4M | 9.2M | 6.31M | 5.94M | 4.32M | 4.88M | 5.33M | 6.51M | 3.64M | 3.54M | 2.75M | 4.72M | 779K | 731K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 26.92M | 23.91M | 19.9M | 18.07M | 12.3M | 11.68M | 7.8M | 8.89M | 3.79M | 3.49M | 3.48M | 3.26M | 1.52M | 1.52M | 1.52M | 1.51M | 1.5M | 1.5M | 1.5M | 1.5M | 1.45M | 1.52M |
Shares Outstanding (Diluted) | 26.92M | 23.91M | 19.9M | 18.07M | 12.3M | 12.38M | 7.8M | 8.89M | 3.79M | 3.49M | 3.48M | 3.26M | 1.52M | 1.52M | 1.52M | 1.51M | 1.5M | 1.5M | 1.5M | 1.5M | 1.45M | 1.52M |
EPS (Basic) | -0.06 | -0.54 | -0.74 | -0.33 | -0.52 | -0.53 | -2.76 | -0.46 | 3.93 | -6.06 | -2.24 | -1.35 | -2.92 | -9.69 | -3.50 | -3.69 | -2.42 | -2.36 | -1.84 | -3.47 | -0.76 | -0.63 |
EPS (Diluted) | -0.06 | -0.54 | -0.74 | -0.33 | -0.52 | -0.50 | -2.76 | -0.46 | 3.93 | -6.06 | -2.24 | -1.35 | -2.92 | -9.69 | -3.50 | -3.69 | -2.42 | -2.36 | -1.84 | -3.47 | -0.76 | -0.63 |
EBITDA | -1.57M | -12.61M | -14.49M | -5.85M | -6.3M | 720K | -21.5M | -3.96M | 9.87M | -20.66M | -7.78M | -4.24M | -3.73M | -14.52M | -5.32M | -5.51M | -3.6M | -3.5M | -2.75M | -5.15M | n/a | -712K |
EBIT | -1.72M | -12.82M | -14.64M | -6M | -6.43M | 585K | -21.51M | -4.08M | 9.87M | -20.94M | -7.78M | -4.32M | -3.81M | -14.56M | -5.33M | -5.55M | -3.64M | -3.54M | -2.75M | -5.15M | -779K | -712K |
Depreciation & Amortization | 151K | 211K | 151K | 148K | 138K | 135K | 7K | 123K | n/a | 284K | 3K | 79K | 78K | 45K | 2K | 40K | 40K | 39K | 250 | n/a | 779K | n/a |
Add to Watchlist
Select watchlists to add or remove UNCY